Relationship of oocyte diameter and risk factors, embryo development during IVF treatment
- Author:
Erdenesuvd D
1
;
Purevjargal N
2
;
Bum Chae Choi
2
;
Park Hyo Young
2
;
Mendsaikhan G
3
;
Bolorchimeg B
3
Author Information
1. Mongolian National University of Medical Science, Mon-CL hospital
2. Mon-CL hospital
3. Mongolian National University of Medical Science
- Publication Type:Journal Article
- Keywords:
in vitro fertilization treatment;
ovarian reserve;
oocyte quality;
dysmorphism
- From:Mongolian Journal of Obstetrics, Gynaecology and Pediatrics
2023;33(1):2393-2397
- CountryMongolia
- Language:Mongolian
-
Abstract:
Relationship of oocyte diameter and risk factors, embryo development during IVF treatment:Introduction: We aimed to determine whether the simple non-invasive measurement of oocyte size using a time-lapse system and assess the impact on occurrence of fertilization and embryo quality in assisted reproduction cycles.
Materials and methods: A retrospective study was performed on 70 infertile patients who underwent the first IVF cycle at Mon-CL hospital. A total of 70 cycles which yielded 483 metaphase II oocytes were included in the analysis. In addition, we evaluated age, body mass index, ovarian reserve markers, fertilization and good embryo rate. The results were processed using SPSS 21.0.
Results: The patients’s age ranged from 22 to 45 years (34.94±4.89 on average). The mean oocyte cytoplasmic diameter was 115.35±5.19 µm, total diameter was 167.61±9.61 µm, zona pellucida thickness was 21.58±4.09. There was no statistically significant association between oocyte size and the occurrence of fertilization or the qualitative embryo classification on day 3. Age, body mass index, cause of infertility, and ovarian response did not affect oocyte sizes.
- Full text:2025111317423507348Судалгаа 2. Д.Эрдэнэсувд ЭХЭМҮТ.docx
